Graham Capital Management, L.P. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Graham Capital Management, L.P. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$93,285
+218.9%
30,092
+43.0%
0.00%
+200.0%
Q1 2023$29,253
-97.3%
21,046
-96.1%
0.00%
-96.9%
Q4 2022$1,064,309
+146.9%
534,829
+416.6%
0.03%
+113.3%
Q1 2022$431,000103,5320.02%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders